Artykuły w czasopismach na temat „Anthracyclines”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Anthracyclines”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Sorensen, K., G. Levitt, D. Sebag-Montefiore, C. Bull i I. Sullivan. "Cardiac function in Wilms' tumor survivors." Journal of Clinical Oncology 13, nr 7 (lipiec 1995): 1546–56. http://dx.doi.org/10.1200/jco.1995.13.7.1546.
Pełny tekst źródłaKrook, James Edward, Akhil Kumar, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, Val Fishman, Sharon Davis i in. "Community use of anthracyclines in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): 1080. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1080.
Pełny tekst źródłaKumar, Akhil, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, James Edward Krook, Val Fishman, Sharon Davis i in. "Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC)." Journal of Clinical Oncology 31, nr 15_suppl (20.05.2013): e11609-e11609. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e11609.
Pełny tekst źródłaNeppelenbroek, Suzanne I. M., Yvonne M. Geurts, Berthe M. P. Aleman, Cecile P. M. Janus, Saskia E. Rademakers, Roel J. de Weijer, Richard W. M. Van Der Maazen i in. "Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors." Journal of Clinical Oncology 39, nr 15_suppl (20.05.2021): 12074. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.12074.
Pełny tekst źródłaBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays i in. "Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group". Journal of Clinical Oncology 30, nr 13 (1.05.2012): 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Pełny tekst źródłaRybczyńska-Tkaczyk, Kamila. "Enhanced Efficiency of the Removal of Cytostatic Anthracycline Drugs Using Immobilized Mycelium of Bjerkandera adusta CCBAS 930". Molecules 26, nr 22 (12.11.2021): 6842. http://dx.doi.org/10.3390/molecules26226842.
Pełny tekst źródłaTorkkell, Sirke, Tero Kunnari, Kaisa Palmu, Juha Hakala, Pekka Mäntsälä i Kristiina Ylihonko. "Identification of a Cyclase Gene Dictating the C-9 Stereochemistry of Anthracyclines from Streptomyces nogalater". Antimicrobial Agents and Chemotherapy 44, nr 2 (1.02.2000): 396–99. http://dx.doi.org/10.1128/aac.44.2.396-399.2000.
Pełny tekst źródłaKrell, J., C. Harper-Wynne, D. Miles, V. Misra, S. Cleator, D. Krell i C. Palmieri. "What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): 1072. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1072.
Pełny tekst źródłaChen, Wei-Wu, Twan Ying Chang, Shu-Min Huang, Ching-Hung Lin, Chiun Hsu, Ann-Lii Cheng i Yen-Shen Lu. "The first two lines of chemotherapy for anthracycline-naïve metastatic breast cancer: A comparative study of efficacy between anthracyclines and nonanthracyclines." Journal of Clinical Oncology 30, nr 15_suppl (20.05.2012): 1061. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1061.
Pełny tekst źródłaGianni, Luca, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna i Gabriel N. Hortobagyi. "Role of Anthracyclines in the Treatment of Early Breast Cancer". Journal of Clinical Oncology 27, nr 28 (1.10.2009): 4798–808. http://dx.doi.org/10.1200/jco.2008.21.4791.
Pełny tekst źródłaSuarato, Antonino, Francesco Angelucci i Cristina Geroni. "Ring-B Modified Anthracyclines". Current Pharmaceutical Design 5, nr 3 (marzec 1999): 217–27. http://dx.doi.org/10.2174/1381612805666230109215627.
Pełny tekst źródłaDozic, Sanela, Erin J. Howden, James R. Bell, Kimberley M. Mellor, Lea M. D. Delbridge i Kate L. Weeks. "Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy". Cells 12, nr 9 (4.05.2023): 1312. http://dx.doi.org/10.3390/cells12091312.
Pełny tekst źródłaGennari, A., M. Sormani, M. Costantini, P. Pronzato, R. Rosso i P. Bruzzi. "Anthracycline regimens versus CMF in the adjuvant treatment of early breast cancer (EBC): A matter of difference". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 569. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.569.
Pełny tekst źródłaEgas Bejar, Daniela E., Joy M. Fulbright, Fernando F. Corrales-Medina, Mary E. Irwin, Blake Johnson i Joya Chandra. "Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects". Blood 122, nr 21 (15.11.2013): 1293. http://dx.doi.org/10.1182/blood.v122.21.1293.1293.
Pełny tekst źródłaBehrouzian, Mahsa, Babak Najibi, Sabahat Haghi, Chehreh Mahdavi, Kaveh Jaseb i Ehsan Ghaedi. "Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose". Current Drug Therapy 15, nr 1 (14.01.2020): 78–84. http://dx.doi.org/10.2174/1574885514666190311145607.
Pełny tekst źródłaKhan, Meraj A., Adam D’Ovidio, Harvard Tran i Nades Palaniyar. "Anthracyclines Suppress Both NADPH Oxidase- Dependent and -Independent NETosis in Human Neutrophils". Cancers 11, nr 9 (7.09.2019): 1328. http://dx.doi.org/10.3390/cancers11091328.
Pełny tekst źródłade Vries, Elisabeth G. E., i Jan G. Zijlstra. "Morpholinyl anthracyclines: Option for reversal of anthracycline resistance". European Journal of Cancer and Clinical Oncology 26, nr 6 (styczeń 1990): 659–60. http://dx.doi.org/10.1016/0277-5379(90)90110-f.
Pełny tekst źródłaMarinello, Jessica, Maria Delcuratolo i Giovanni Capranico. "Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives". International Journal of Molecular Sciences 19, nr 11 (6.11.2018): 3480. http://dx.doi.org/10.3390/ijms19113480.
Pełny tekst źródłaMontaigne, David, Christopher Hurt i Remi Neviere. "Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies". Biochemistry Research International 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/951539.
Pełny tekst źródłaQiao, Xiaohang, Sabina Y. van der Zanden, Dennis P. A. Wander, Daniel M. Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne van Duikeren i in. "Uncoupling DNA damage from chromatin damage to detoxify doxorubicin". Proceedings of the National Academy of Sciences 117, nr 26 (17.06.2020): 15182–92. http://dx.doi.org/10.1073/pnas.1922072117.
Pełny tekst źródłaHerzig, R. H., H. M. Lazarus, S. N. Wolff, G. L. Phillips i G. P. Herzig. "High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia." Journal of Clinical Oncology 3, nr 7 (lipiec 1985): 992–97. http://dx.doi.org/10.1200/jco.1985.3.7.992.
Pełny tekst źródłaLevina, V. D., M. G. Poltavskaya, V. P. Sedov, P. Sh Chomakhidze, L. V. Bolotina, T. I. Deshkina, M. D. Kuklina i in. "The role of left ventricle global longitudinal srain in prediction of chemotherapy — induced cardiotoxicity in breast cancer patients treated by low and moderate cumulative doses of anthracyclines". Medical alphabet, nr 33 (12.01.2023): 19–26. http://dx.doi.org/10.33667/2078-5631-2022-33-19-26.
Pełny tekst źródłaAl-Batran, S., M. Scholz i E. Jäger. "Anthracycline-rechallenge using pegylated liposomal doxorubicin (PLD) in previously treated patients with metastatic breast cancer (MBC): A meta-analysis using pooled individual data from four prospective trials". Journal of Clinical Oncology 27, nr 15_suppl (20.05.2009): 1047. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1047.
Pełny tekst źródłaMenna, Pierantonio, i Emanuela Salvatorelli. "Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview". Chemotherapy 62, nr 3 (2017): 159–68. http://dx.doi.org/10.1159/000455823.
Pełny tekst źródłaVeiga, Lene H. S., Rochelle E. Curtis, Lindsay M. Morton, Diana Withrow, Rebecca M. Howell, Susan A. Smith, Rita Weathers i in. "Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS)." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 10053. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10053.
Pełny tekst źródłaAplenc, R., J. Blanco, W. Leisenring, S. Davies, M. Relling, L. Robison, C. Sklar, M. Stovall i S. Bhatia. "Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS)". Journal of Clinical Oncology 24, nr 18_suppl (20.06.2006): 9004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9004.
Pełny tekst źródłaArmenian, Saro, i Smita Bhatia. "Predicting and Preventing Anthracycline-Related Cardiotoxicity". American Society of Clinical Oncology Educational Book, nr 38 (maj 2018): 3–12. http://dx.doi.org/10.1200/edbk_100015.
Pełny tekst źródłaMata, Danilo Giffoni M. M., Matthew Castelo, Rinku Sutradhar, Lena Nguyen, Neil Faught, Danielle Rodin, Ezra Hahn i in. "Abstract P4-06-10: Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? – A Real World Comparison in the Neoadjuvant Setting". Cancer Research 83, nr 5_Supplement (1.03.2023): P4–06–10—P4–06–10. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-06-10.
Pełny tekst źródłaHamilton, Joseph Z., Kerry Klussman, Rebecca Mahzereh, Jessica Simmons, Michelle Ulrich, Shyra J. Gardai, Peter D. Senter i Patrick J. Burke. "Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs". Cancer Research 83, nr 7_Supplement (4.04.2023): 2013. http://dx.doi.org/10.1158/1538-7445.am2023-2013.
Pełny tekst źródłaKremer, L. C. M., E. C. van Dalen, M. Offringa, J. Ottenkamp i P. A. Voûte. "Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study". Journal of Clinical Oncology 19, nr 1 (1.01.2001): 191–96. http://dx.doi.org/10.1200/jco.2001.19.1.191.
Pełny tekst źródłaFulbright, Joy Marie, i Joya Chandra. "“Limiting Anthracycline-Induced Cardiotoxicity Using Amrubicin in Leukemia Systems”." Blood 114, nr 22 (20.11.2009): 3760. http://dx.doi.org/10.1182/blood.v114.22.3760.3760.
Pełny tekst źródłaHarahsheh, Ashraf, Sanjeev Aggarwal, Michael D. Pettersen i Thomas L’Ecuyer. "Diastolic function in anthracycline-treated children". Cardiology in the Young 25, nr 6 (23.09.2014): 1130–35. http://dx.doi.org/10.1017/s1047951114001760.
Pełny tekst źródłaPiccart-Gebhart, Martine J., Tomasz Burzykowski, Marc Buyse, George Sledge, James Carmichael, Hans-Joachim Lück, John R. Mackey i in. "Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer". Journal of Clinical Oncology 26, nr 12 (20.04.2008): 1980–86. http://dx.doi.org/10.1200/jco.2007.10.8399.
Pełny tekst źródłaMegias-Vericat, Juan Eduardo, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González i in. "DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA". Mediterranean Journal of Hematology and Infectious Diseases 11, nr 1 (26.02.2019): e2019016. http://dx.doi.org/10.4084/mjhid.2019.016.
Pełny tekst źródłaCreutzig, Ursula, Sylke Diekamp, Martin Zimmermann i Dirk Reinhardt. "Long Term Data on Anthracycline Cardiotoxicity in 547 Children with AML." Blood 108, nr 11 (1.11.2006): 2014. http://dx.doi.org/10.1182/blood.v108.11.2014.2014.
Pełny tekst źródłaCheong, Alison, Sean McGrath i Suzanne Cutts. "Anthracyclines". WikiJournal of Medicine 5, nr 1 (6.12.2018): 1. http://dx.doi.org/10.15347/wjm/2018.001.
Pełny tekst źródła&NA;. "Anthracyclines". Reactions Weekly &NA;, nr 433 (styczeń 1993): 6. http://dx.doi.org/10.2165/00128415-199304330-00012.
Pełny tekst źródła&NA;. "Anthracyclines". Reactions Weekly &NA;, nr 371 (październik 1991): 4–5. http://dx.doi.org/10.2165/00128415-199103710-00011.
Pełny tekst źródła&NA;. "Anthracyclines". Reactions Weekly &NA;, nr 1293 (marzec 2010): 9–10. http://dx.doi.org/10.2165/00128415-201012930-00021.
Pełny tekst źródłaDesmedt, Christine, Angelo Di Leo, Evandro de Azambuja, Denis Larsimont, Benjamin Haibe-Kains, Jean Selleslags, Suzette Delaloge i in. "Multifactorial Approach to Predicting Resistance to Anthracyclines". Journal of Clinical Oncology 29, nr 12 (20.04.2011): 1578–86. http://dx.doi.org/10.1200/jco.2010.31.2231.
Pełny tekst źródłaCheah, Irwin K., Richard M. Y. Tang, Xiaoyuan Wang, Karishma Sachaphibulkij, Suet Yen Chong, Lina H. K. Lim, Jiong-Wei Wang i Barry Halliwell. "Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine". Antioxidants 12, nr 2 (30.01.2023): 320. http://dx.doi.org/10.3390/antiox12020320.
Pełny tekst źródłaAttina’, Giorgio, Silvia Triarico, Alberto Romano, Palma Maurizi, Stefano Mastrangelo i Antonio Ruggiero. "Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment". Biomedical and Pharmacology Journal 15, nr 3 (29.09.2022): 1311–21. http://dx.doi.org/10.13005/bpj/2468.
Pełny tekst źródłaPaukovcekova, Silvia, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda i Renata Veselska. "Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors". International Journal of Molecular Sciences 23, nr 15 (1.08.2022): 8549. http://dx.doi.org/10.3390/ijms23158549.
Pełny tekst źródłaFranco, Vivian I., Jacqueline M. Henkel, Tracie L. Miller i Steven E. Lipshultz. "Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines". Cardiology Research and Practice 2011 (2011): 1–13. http://dx.doi.org/10.4061/2011/134679.
Pełny tekst źródłaPuzzovivo, Agata, Agnese Maria Fioretti, Carla Minoia, Roberta Villoni, Santa Carbonara, Giusi Graziano, Fabio Pavone, Attilio Guarini i Stefano Oliva. "Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin’s Lymphoma: The Tei Index Evaluation". Journal of Personalized Medicine 12, nr 2 (16.02.2022): 290. http://dx.doi.org/10.3390/jpm12020290.
Pełny tekst źródłaAngelotti, Austin, Deena Snoke, Rachel Cole, Genevieve Sparagna i Martha Belury. "Characterizing Cardiolipin Species in the Hearts After Anthracycline Administration". Current Developments in Nutrition 5, Supplement_2 (czerwiec 2021): 934. http://dx.doi.org/10.1093/cdn/nzab050_001.
Pełny tekst źródłaTagawa, Michihito, Genya Shimbo, Akiko Uemura i Kotaro Matsumoto. "Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines". Open Veterinary Journal 11, nr 1 (19.03.2021): 6–10. http://dx.doi.org/10.4314/ovj.v11i1.2.
Pełny tekst źródłaGschwantler-Kaulich, D., A. Fink-Retter, T. Bachrich, M. Ledesma, E. Ruecklinger, E. Kubista i C. F. Singer. "Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer". Journal of Clinical Oncology 25, nr 18_suppl (20.06.2007): 11098. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11098.
Pełny tekst źródłaDadson, Keith, Oscar Calvillo-Argüelles, Paaladinesh Thavendiranathan i Filio Billia. "Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms". Clinical Science 134, nr 13 (lipiec 2020): 1859–85. http://dx.doi.org/10.1042/cs20190653.
Pełny tekst źródłaChong, Wei, Huikun Zhang, Zhifang Guo, Limin Yang, Ying Shao, Xiaoli Liu, Yawen Zhao i in. "Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity". Cell Death & Differentiation 28, nr 1 (19.08.2020): 382–400. http://dx.doi.org/10.1038/s41418-020-00607-9.
Pełny tekst źródła